COPD gradually damages delicate structures inside the eye, even though the disease is best known for what it does to the lungs. Chronic low oxygen levels, persistent inflammation, and the medications used to manage breathing all take a toll on eye health. The retina, the choroid layer beneath it, and the optic nerve are especially vulnerable, and a growing body of research describes this cross-organ damage as a “lung-eye axis.” The effects range from subtle structural thinning that only imaging can detect to clinically meaningful conditions like cataracts, macular degeneration, and even acute glaucoma attacks.
How Lung Disease Reaches the Eyes
The connection between COPD and eye damage runs through four overlapping pathways: chronic systemic inflammation, intermittent or persistent low oxygen levels, oxidative stress, and damage to the lining of small blood vessels throughout the body.1PubMed Central. The COPD-driven “lung-eye axis”: mechanisms and clinical evidence of ocular disease The retina and optic nerve are among the most oxygen-hungry tissues in the body. They depend on a dense web of tiny blood vessels to stay nourished, so when COPD starves the bloodstream of oxygen or floods it with inflammatory molecules, these tissues feel the consequences quickly.
This is not just theoretical. Imaging studies have now documented measurable physical changes in the eyes of people with COPD, including narrower retinal blood vessels, thinner nerve fiber layers, and reduced blood flow to the area behind the retina. The damage tends to track with disease severity: the worse the COPD, the more pronounced the eye findings.
Thinning of the Retinal Nerve Fiber Layer
One of the most consistent findings in the research is that the retinal nerve fiber layer, the thin sheet of nerve tissue at the back of the eye that transmits visual signals to the brain, is measurably thinner in people with COPD than in healthy controls. In one study, the average thickness was about 100 micrometers in the COPD group compared to roughly 106 in the control group, with the most pronounced thinning in the lower portion of the retina.2PubMed. New aspect for systemic effects of COPD: eye findings A separate study confirmed similar reductions and found that the ganglion cell layer, another structure critical for vision, was also significantly thinner across all sectors in people with severe COPD.3PubMed. The evaluation of retinal and choroidal structural changes by optical coherence tomography in patients with chronic obstructive pulmonary disease
An Egyptian study found even steeper differences: average nerve fiber layer thickness of about 79 micrometers in the COPD group versus 96 in controls. That study also showed the degree of thinning correlated with how advanced the COPD was, with people in later disease stages showing the most dramatic loss.4The Egyptian Journal of Bronchology. Evaluation of the impact of COPD severity grading and oxygen saturation on the retinal nerve fiber layer thickness and subfoveal choroidal thickness in COPD patients The nerve fiber layer thinning pattern in COPD resembles what you see in early glaucoma, which raises the question of whether chronic low oxygen itself could contribute to gradual optic nerve damage over time.
For most people with COPD, this thinning does not cause noticeable vision changes on its own, at least not in the early stages. The concern is cumulative: if the nerve fiber layer keeps deteriorating as the lung disease progresses, it may eventually contribute to visual field loss, particularly if other risk factors for eye disease are also present.
Retinal Blood Vessel Changes
Beyond structural thinning, COPD also reshapes the blood vessels that supply the retina. One imaging study found that vascular density dropped in the area surrounding the central visual field, likely driven by the combination of chronic low oxygen and damage to the inner lining of blood vessels.5PubMed Central. Retinal Vascular Changes in Patients with Chronic Obstructive Pulmonary Disease: An Optical Coherence Tomography Angiography Study In simpler terms, the small blood vessels that feed the retina become sparser and less capable of delivering oxygen where it is needed.
Research examining the caliber of the retinal arteries and veins in COPD patients found that older patients tended to have narrower vessels overall. Lower resting oxygen saturation and reduced lung function were both associated with narrower retinal arteries, while higher levels of systemic inflammation tracked with wider veins.6PubMed Central. Structural analysis of retinal blood vessels in patients with COPD during a pulmonary rehabilitation program Wider retinal veins paired with narrower arteries is a pattern that has been linked in other research to cardiovascular risk, reinforcing the idea that what COPD does to the lungs reverberates through the entire vascular system.
A Thinner Choroid
The choroid is a layer of blood vessels sandwiched between the retina and the white outer wall of the eye. Its job is to supply oxygen and nutrients to the outer retina, including the light-sensitive photoreceptor cells you rely on for sharp central vision. Multiple studies have found that this layer is significantly thinner in people with COPD.
In one study, the subfoveal choroidal thickness (measured directly behind the center of the macula) averaged about 239 micrometers in COPD patients versus 285 in controls.7PubMed Central. To Evaluate the Effect of Chronic Obstructive Pulmonary Disease on Retinal and Choroidal Thicknesses Measured by Optical Coherence Tomography Another study confirmed the same pattern and showed that even patients during a stable phase of COPD had thinner choroids than healthy people, with no meaningful difference between the stable group and those in the middle of a flare-up.8PubMed Central. Choroid and Retinal Nerve Fiber Layer Thickness in Patients with Chronic Obstructive Pulmonary Disease Exacerbation This suggests the choroidal thinning is a chronic consequence of the disease, not just a temporary effect of acute illness.
Again, severity matters. The Egyptian study that tracked nerve fiber layer thickness also measured the choroid and found that people with more advanced COPD had dramatically thinner readings, averaging about 213 micrometers versus 355 in controls.4The Egyptian Journal of Bronchology. Evaluation of the impact of COPD severity grading and oxygen saturation on the retinal nerve fiber layer thickness and subfoveal choroidal thickness in COPD patients A thinner choroid means less blood supply to the photoreceptors, which could set the stage for vision problems down the road, particularly conditions like macular degeneration that already involve choroidal dysfunction.
A Higher Risk of Macular Degeneration
Age-related macular degeneration, the leading cause of irreversible vision loss in older adults, appears to be more common in people with COPD. A large population-based study found that the COPD group developed macular degeneration at a rate roughly 25 percent higher than matched controls without COPD. The increased risk applied to both the “wet” form (more aggressive, involving abnormal blood vessel growth) and the “dry” form (more gradual, involving tissue breakdown), though the bump in risk was larger for the wet type.9PubMed Central. Population-based retrospective cohort study on risk of age-related macular degeneration in people with chronic obstructive pulmonary disease
This connection makes sense given the structural changes described above. If COPD is already thinning the choroid and reducing blood flow to the outer retina, the tissue may be more vulnerable to the kind of degeneration that leads to macular disease. The combination of chronic oxygen deprivation, inflammation, and oxidative stress is essentially a recipe for accelerating the aging process in the macula. If you have COPD and you are over 50, regular dilated eye exams become especially important for catching macular degeneration early, when treatment options for the wet form are most effective.
Cataracts and Inhaled Steroids
Many people with COPD use inhaled corticosteroids daily to control airway inflammation. These medications are effective at reducing flare-ups, but long-term use carries a well-documented risk for the eyes: cataracts. A systematic review and meta-analysis looking at corticosteroid exposure in people with asthma and COPD found that posterior subcapsular cataracts were the most common subtype associated with steroid use.10PubMed Central. Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis This particular type of cataract forms on the back surface of the lens and tends to interfere with reading and bright-light vision relatively early compared to other cataract types.
The risk generally increases with higher doses and longer duration of use. This does not mean you should stop your inhaled steroids, which remain one of the most important tools for preventing COPD exacerbations. But it does mean you should tell your eye doctor about your medications and get regular lens examinations. If a posterior subcapsular cataract starts forming, early detection lets you and your doctors weigh the options, whether that is adjusting medication, monitoring the cataract, or eventually opting for surgery if vision becomes impaired enough.
Nebulizer-Triggered Glaucoma Attacks
One of the more alarming eye complications from COPD treatment is acute angle-closure glaucoma triggered by nebulized bronchodilator medications. This happens when the mist from a nebulizer drifts into the eyes, usually because the face mask does not fit snugly. The anticholinergic drugs commonly nebulized for COPD, such as ipratropium, can dilate the pupil when they contact the eye surface. In people with a narrow drainage angle in the eye (a common anatomical variant, especially in older adults and people of certain ethnic backgrounds), this pupil dilation can block the outflow of fluid, causing eye pressure to spike suddenly.11American Journal of Emergency Medicine. Bilateral acute angle-closure glaucoma after bronchodilator therapy
The symptoms come on fast: severe eye pain, blurred vision, halos around lights, nausea, and a visibly red eye. This is a medical emergency that can cause permanent vision loss if not treated within hours. It has been reported with both ipratropium and combination ipratropium-salbutamol nebulizers. The key prevention measure is simple: make sure the face mask fits properly so the aerosol cloud does not leak upward into the eyes. Some patients and clinicians prefer a mouthpiece attachment instead of a face mask, which eliminates eye contact entirely.12PubMed Central. Patients’ practices and experiences of using nebuliser therapy in the management of COPD at home If you already know you have narrow angles or a history of glaucoma, mention this to whoever prescribes your nebulizer so you can be set up with the right delivery device from the start.
Dry Eye and the Smoking Connection
Most people with COPD have a significant smoking history, and smoking itself is a direct irritant to the eye surface. But the effect goes beyond simple irritation. Research on current smokers has shown that tear production, the density of mucus-producing cells on the eye surface, and the concentration of a key protective protein in tears are all reduced compared to non-smokers. The more pack-years of smoking a person has accumulated, the worse these measures tend to be.13PubMed Central. Impact of Cigarette Smoking on Tear Function and Correlation between Conjunctival Goblet Cells and Tear MUC5AC Concentration in Office Workers
This means many people who develop COPD arrive at their diagnosis with eyes that are already compromised. The tear film, the thin layer of moisture that protects and lubricates the front of the eye, may be thinner and less stable. When you add in supplemental oxygen therapy (which dries out mucous membranes) and the general dehydration that comes with chronic illness, you get a recipe for persistent dry eye symptoms: burning, grittiness, foreign-body sensation, blurred vision that fluctuates with blinking, and eyes that water paradoxically (your eyes reflexively overproduce watery tears when the protective mucus layer is inadequate).
Artificial tears can help manage symptoms. Preservative-free formulations are generally better for frequent use because the preservatives in standard drops can themselves irritate a compromised eye surface. If you are on supplemental oxygen, running a humidifier in your bedroom and keeping airflow from the nasal cannula pointed away from your eyes can reduce overnight drying.
Papilledema During Severe COPD Flare-Ups
A rare but serious eye finding in COPD is papilledema, the swelling of the optic nerve head at the back of the eye. This can happen during severe exacerbations when carbon dioxide levels in the blood climb dangerously high. In one documented case, a 61-year-old man presented during a severe COPD flare-up with confusion and headache. His carbon dioxide levels were extremely elevated, and examination revealed bilateral papilledema caused by brain swelling from the excess carbon dioxide. After treatment with non-invasive ventilation brought his carbon dioxide back down, both the neurological symptoms and the optic nerve swelling resolved completely.14PubMed Central. Hypercapnia-induced cerebral oedema in a patient with COPD exacerbation
Papilledema from high carbon dioxide is considered under-recognized in the COPD population, partly because the confusion and headache that accompany a severe flare-up can overshadow any visual complaints, and partly because eye exams are not routinely performed in acute respiratory care settings. The practical message is that sudden-onset headaches, visual blurring, or transient visual blackouts during a COPD exacerbation should prompt a closer look, as these symptoms may signal dangerously high carbon dioxide levels that need aggressive correction.
Why Eye Screening Is Not Yet Standard in COPD Care
Despite accumulating evidence that COPD causes measurable eye damage, routine eye screening is not yet part of standard COPD management guidelines. One review described ocular involvement in COPD as an “underrecognized comorbidity,” noting that most of the structural damage affects the back of the eye and would not be apparent without specialized imaging.15Respiratory Medicine. Ocular manifestations in COPD patients. An underrecognized comorbidity The retinal thinning, choroidal changes, and vascular narrowing identified in research studies require optical coherence tomography or similar technology to detect. A standard vision chart test would miss them entirely.
Some researchers have argued that future COPD guidelines should incorporate ocular findings alongside the disease’s other recognized systemic effects like osteoporosis, cardiovascular disease, and depression.2PubMed. New aspect for systemic effects of COPD: eye findings Whether that happens will depend on larger studies establishing exactly how much the structural changes translate into functional vision loss over time. In the meantime, if you have COPD, scheduling a comprehensive dilated eye exam every year or two is a reasonable step that most pulmonologists would support even if the formal guidelines have not caught up yet. Let your eye doctor know about your COPD diagnosis, your oxygen saturation levels if you track them, and your full medication list, particularly any inhaled steroids or nebulized anticholinergics. That context helps them know what to look for and how aggressively to monitor.
Corneal Changes and Anterior Segment Findings
Most of the research on COPD and the eye has focused on the retina and choroid at the back of the eye, but evidence is beginning to emerge that the front of the eye may be affected as well. Structural abnormalities of the cornea have been described in COPD patients, though this area of research is less developed than the retinal and choroidal work.15Respiratory Medicine. Ocular manifestations in COPD patients. An underrecognized comorbidity The cornea, like the retina, depends on adequate oxygenation. It is one of the few tissues in the body that gets a significant portion of its oxygen directly from the air rather than exclusively from blood vessels, which makes it sensitive to both the hypoxic conditions created by COPD and to the local drying effects of supplemental oxygen.
Corneal changes in the context of COPD are still being characterized, and it is too early to say exactly how much clinical significance they carry. But they reinforce the broader point: COPD is not just a lung disease. It is a systemic condition that leaves fingerprints across multiple organ systems, and the eye, with its extreme sensitivity to oxygen, blood flow, and inflammation, turns out to be one of the organs where those fingerprints are most readily detected.